Global IVF AI Target mid to large IVF clinics globally by highlighting Life Whisperer’s AI embryo viability and genetics assessment tools as a proven pathway to improve success rates and reduce time-to-pregnancy, a key value proposition for clinics seeking higher patient satisfaction and competitive differentiation.

Clinical Spotlight Leverage past and upcoming conference exposure at ASRM and ESHRE to open opportunities for speaking engagements, pilot programs, and co-branded research with clinics that want to adopt AI-enabled IVF solutions and showcase clinical outcomes.

Partnership Pipeline Position Life Whisperer as the fertility arm of Presagen to pursue strategic collaborations with global IVF networks, leveraging existing CLINIC collaborations and CE-marked capabilities to accelerate adoption in Europe, UK, and other regulated markets.

SMB to ASCs Identify opportunities with smaller clinics and independent fertility centers seeking affordable AI tooling by demonstrating a scalable deployment model, cost-to-outcome improvements, and quick ROI given current revenue levels under a million dollars.

Growth Funding Use the current funding and lean headcount to emphasize agility and faster deployment cycles; propose co-investment or tiered pricing with service-level guarantees to attract clinics wary of higher CapEx while expanding market reach.